Intellipharmaceutics International Inc. Quarterly Operating Income (Loss) in CAD from Q1 2016 to Q2 2017

Taxonomy & unit
us-gaap: CAD and USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Intellipharmaceutics International Inc. annual/quarterly Operating Income (Loss) history and growth rate from Q1 2016 to Q2 2017.
  • Intellipharmaceutics International Inc. Operating Income (Loss) for the quarter ending May 31, 2017 was -CA$1.75M, a 8.13% increase year-over-year.
  • Intellipharmaceutics International Inc. annual Operating Income (Loss) for 2018 was -CA$13.3M, a 61.2% decline from 2017.
  • Intellipharmaceutics International Inc. annual Operating Income (Loss) for 2017 was -CA$8.27M, a 16.1% increase from 2016.
  • Intellipharmaceutics International Inc. annual Operating Income (Loss) for 2016 was -CA$9.85M, a 38.5% decline from 2015.
Operating Income (Loss), Quarterly (CAD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2017 -1.75M +155K +8.13% Mar 1, 2017 May 31, 2017 6-K 2017-07-11
Q1 2017 -1.85M +245K +11.7% Dec 1, 2016 Feb 28, 2017 6-K 2017-04-12
Q2 2016 -1.91M Mar 1, 2016 May 31, 2016 6-K 2017-07-11
Q1 2016 -2.09M Dec 1, 2015 Feb 29, 2016 6-K 2017-04-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.